Flu News and Research

RSS

Study offers insights into how COVID-19 damages the heart

University of Queensland researchers have discovered how COVID-19 damages the heart, opening the door to future treatments.

29 Sep 2022

Religious leaders influence COVID-19 vaccine decision-making among Evangelical Christians

Evangelical Christians who sought information from their religious leaders about getting the COVID-19 vaccine were significantly less likely to be vaccinated, while evangelicals who spoke with a health care provider about the vaccine were more likely to be vaccinated, according to a new Virginia Commonwealth University-led study involving a survey of 531 self-identified evangelical Christians in the U.S.

28 Sep 2022

Debunking ‘man flu’

Researchers debunk man flu based on a review of available evidence.

28 Sep 2022

Specific N-glycans regulate the development and functional maturation of SARS-CoV-2 spike protein

If you're an avid reader of science news, you've probably heard of viral proteins such as the COVID-19 spike protein.

27 Sep 2022

What is the impact of SARS-CoV-2 infection on semen parameters and sex hormones?

A new study aimed to systematically review studies investigating sex hormones and semen parameters in COVID-19 patients to provide a better understanding and treatment approach.

27 Sep 2022

Rodents can serve as reservoirs for fungal infections, study reveals

Fungal diseases in the human population are on the rise, so it is important for health authorities to understand where these pathogens come from.

26 Sep 2022

Is covid ‘under control’ in the US? Experts say yes

President Joe Biden caused a stir in a “60 Minutes” interview on Sept. 18 when he declared that the covid-19 pandemic is over.

26 Sep 2022

Researchers examine the impact of COVID-19 measures on influenza circulation in Canada

Shinhye et al. look into the impact of COVID-19 measures on influenza circulation in Canada between 2020 and 2022 and the vaccine effectiveness against late-season influenza illness due to A(H3N2) in 2022.

23 Sep 2022

Common genetic variants of APOE associated with COVID mortality

It may be the most baffling quirk of COVID: What manifests as minor, flu-like symptoms in some individuals spirals into severe disease, disability, and even death in others.

21 Sep 2022

Disruption of actin cytoskeleton is key to triggering human immune response, research finds

Researchers from Cleveland Clinic's Florida Research and Innovation Center (FRIC) found that disruption of a cellular structure, known as the actin cytoskeleton, is a "priming signal" for the body to respond to a virus.

15 Sep 2022

Bivalent recombinant vaccine protects against SARS-CoV-2 and influenza in animal models

In a new study, researchers developed a recombinant bivalent vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza viruses.

15 Sep 2022

Experts question the role of white mulberry in the death of Congressman’s wife

Scientists, doctors, and pathologists are questioning the Sacramento County coroner's conclusion that Lori McClintock's death was related to white mulberry, a plant that has been used as an herbal remedy for centuries — and one that the coroner's botanical consultant called "not toxic" in a letter to her office.

14 Sep 2022

U-M scientists give tips about how teachers can keep classrooms safe from COVID-19

Since the Centers for Disease Control and Prevention acknowledged SARS-CoV-2 was airborne in spring 2020, University of Michigan aerosol scientists Andrew Ault and Kerri Pratt have advised public school systems on how to mitigate the transmission of COVID-19 in the classroom.

14 Sep 2022

What are the intensities and frequencies of extreme epidemics?

In a new study, researchers assessed the intensities and frequencies of extreme novel epidemics.

13 Sep 2022

Did the US jump the gun with the new omicron-targeted vaccines?

Last month, the FDA authorized omicron-specific vaccines, accompanied by breathless science-by-press release and a media blitz.

12 Sep 2022

Phase 3 clinical trial commences to evaluate antiviral for monkeypox

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States.

9 Sep 2022

Using wastewater-based epidemiology to monitor monkeypox

Monkeypox, a virus that causes painful rashes and flu-like symptoms, is spreading rapidly throughout many parts of the world, including the U.S. To get a fast understanding of how the virus is moving through communities, researchers reporting in ACS' Environmental Science & Technology Letters suggest turning to wastewater epidemiology.

8 Sep 2022